← Eichor
Study identifier: NCT06732791 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparative Analysis of MGAP and GAP Trauma Scores in Predicting Outcomes for Multiple Trauma Patients

Condition: Trauma  ·  Sponsor: Al-Nahrain University

PhaseN/A
Planned participants522
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this prospective cohort study is to compare the predictive accuracy of the MGAP and GAP trauma scores in determining the prognosis of multiple trauma patients admitted to the emergency department at Al-Kadhimiya Teaching Hospital, Iraq. The main questions it aims to answer are: Does the MGAP score provide a more accurate prediction of outcomes compared to the GAP score? Are there specific subgroups of trauma patients where one score demonstrates superior predictive utility over the other? Participants will: Be assessed using both the MGAP and GAP scores upon admission to the emergency department. Have their clinical outcomes, including mortality, length of stay, and need for surgery, tracked throughout their hospital stay.

This description comes directly from the study's public registry record.

Talk to the study team

Abdulillah R. Khamees  ·  +9647838571013  ·  allaabed987@ced.nahrainuniv.edu.iq

Always discuss trial participation with your own doctor first.

Locations (1)

College of Medicine - Al-Nahrain UniversityBaghdad, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06732791